Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€48.16
23.08.22
€65.00
23.08.23
1.00%
24.08.23

buy
Galaxy Digital Holdings Ltd.

Start price
Target price
Perf. (%)
€4.95
23.08.22
-
23.08.27
4.02%
19.09.22

Very high cyclical dependencies
Probably not worthwhile Investment
buy
Eo2 S.A.

Start price
Target price
Perf. (%)
€6.20
23.08.22
-
23.08.23
-2.26%
24.08.23

buy
Siemens AG

Start price
Target price
Perf. (%)
€103.18
23.08.22
€150.00
23.09.22
-1.16%
31.08.22

Well known brand
High dividend yield expected
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€18.81
23.08.22
€45.00
23.08.25
-60.21%
25.04.23

Could be worthwhile Investment >10% per year
buy
BICO Group AB

Start price
Target price
Perf. (%)
€3.72
23.08.22
€10.00
23.09.22
-31.54%
24.09.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€3.11
23.08.22
-
23.08.23
16.02%
01.11.22

Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
EBIT growth > 30% per year expected
buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€2.41
23.08.22
-
23.08.23
21.54%
01.11.22

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
buy
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€2.85
23.08.22
-
23.08.23
39.76%
01.11.22

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Very small cyclical dependencies
buy
Sektkellerei Schloss Wachenheim AG

Start price
Target price
Perf. (%)
€16.60
23.08.22
-
23.08.23
-3.01%
23.08.23

buy
ETFS Physical Silver

Start price
Target price
Perf. (%)
-
23.08.22
-
23.08.23
0.00%
23.08.23

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€65.38
23.08.22
-
23.08.23
6.12%
23.08.23

buy
Albemarle Corp

Start price
Target price
Perf. (%)
€276.40
23.08.22
-
23.08.23
-37.30%
23.08.23

buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€44.79
23.08.22
-
23.08.23
-44.30%
23.08.23

buy
Square Inc.

Start price
Target price
Perf. (%)
€73.49
22.08.22
-
22.08.23
-16.42%
28.10.22

buy
Context Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.95
22.08.22
€0.000
22.08.23
-3.71%
03.09.22

buy
Intel Corp.

Start price
Target price
Perf. (%)
€34.06
22.08.22
€44.00
21.03.23
-20.14%
21.03.23

buy
micromobility.com Inc.

Start price
Target price
Perf. (%)
€47.50
22.08.22
-
22.08.23
-31.05%
30.08.22

Atlanticus Holdings Corp

Start price
Target price
Perf. (%)
€33.30
22.08.22
-
22.08.23
-25.53%
24.04.23

Probably not worthwhile Investment
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€94.45
22.08.22
-
22.09.22
-5.58%
30.08.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Revenue growth >5% per year expected
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€4.32
22.08.22
-
22.08.23
-27.78%
03.09.22

buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€11.11
22.08.22
-
22.08.23
-20.80%
03.09.22

Risky Investment
buy
Max Automation AG

Start price
Target price
Perf. (%)
€4.23
22.08.22
€6.00
22.08.23
0.95%
03.09.22

Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
High dividend yield expected
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€36.50
22.08.22
€66.00
22.08.23
-8.22%
03.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€25.58
22.08.22
€44.00
22.08.23
-5.00%
03.09.22

Could be very worthwhile Investment >20% year
Capable Management
Good culture
Innovative